| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |